Analysts have suggested that the US market for drugs to treat UDCA-refractory PBC could be worth $1.5 billion or more per year. Gilead acquired Livdelzi – an oral PPAR delta agonist – as the ...

There isn’t a cure for PBC, but the right treatment plan can slow its progress and boost your quality of life as you live with it.

Dr Palak Trivedi of the University of Birmingham in the UK, who presented the study at EASL, noted that there is no cure for PBC and while current drugs can slow liver damage and stop progression ...

If medications are not helping ... Primary biliary cholangitis, or primary biliary cirrhosis, is a chronic and serious condition. When diagnosed, people with elevated bilirubin levels have ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...

The association between celiac disease and primary biliary cirrhosis is well established. The breakdown of gut–liver axis equilibrium plays a central role in the development of immune disorders ...

The People's Bank of China (PBC), the central bank, said on Thursday that it will adjust and optimize the strength and pace of policies at the appropriate time based on domestic and international ...